Upcoming Program

MATEC-Kansas/Nebraska and MATEC-Wisconsin

Lentocilin and Bicillin in the Treatment of Syphilis: Clinical Use in Indian Health Settings,

Including Consideration for People with HIV

CDR Rebecca Geiger, PharmD, MHA, BCACP

OCA HIV/HCV/STI Coordinator,

Haskell Indian Health Center


CDR Rebecca Geiger is a board certified clinical pharmacist and quality officer at the Haskell Indian Health Center in Lawrence, Kansas. She earned her Doctorate in pharmacy from Southwestern Oklahoma State University in 2008 and a Master’s in healthcare administration from Oklahoma State University in 2015. CDR Geiger began her career in the Indian Health Service in 2009 and implemented the first pharmacist-led hepatitis C treatment clinic in Oklahoma in 2011. She currently directs patient care to individuals receiving HIV care, PrEP, PEP, and/or STI treatment and serves as the Oklahoma City Area HIV/HCV/STI Coordinator.

 

Additionally, CDR Geiger serves on the Oklahoma Native HIV Taskforce, the OSDH Harm Reduction Council, and the National Indian Health Service HOPE Committee. She is passionate about improving access to care so patients are healthy, whole, and thrive.

Friday, February 20th, 2026

12:00 - 1:00PM CST | 1:00 - 2:00PM EST

Via Zoom – link will be sent upon registration

Note: This program will NOT be recorded


Target audience: Health care providers/professionals working with Native populations and Tribal leaders

 

Learning Objectives:

By the end of this session, participants will be able to:

  • Describe the pharmacologic differences and clinical indications for Lentocilin and Bicillin in the treatment of syphilis.
  • Apply current syphilis treatment guidelines to select appropriate penicillin formulations for patients in Indian Health Service facilities.
  • Identify best practices for administration, dosing, and follow-up of Lentocilin and Bicillin to improve treatment outcomes in American Indian and Alaska Native populations, including those with HIV.

 

Fees: There is no fee for participants, but registration is required by Thursday, February 19, 2026.

 

Questions? Please e-mail stusher@kumc.edu

Continuing Education Credit

Physicians, Pharmacists, Nurses, Other Participants

CME, CNE, Pharmacy CE, AND Certificates of Attendance – PENDING

 

Physicians: “The Nebraska Medical Education Trust designates this in-person training for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”

“This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Nebraska Medical Education Trust and St. Louis Prevention Training Center. The Nebraska Medical Education Trust is accredited by the Nebraska Medical Association to provide continuing medical education for physicians.” 

 

Pharmacists: The University of Cincinnati College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing education.

 

Nursing

Kansas City CARE Clinic is approved as provider of continuing nursing education by the Kansas State Board of Nursing. This course offering approved for 1.5 contact hours applicable for RN or LPN re-licensure. Kansas State Board of Nursing Approved Provider Number: LT0256-0609.

 

All Other Participants will receive a Certificate of Attendance

 

COMPLETION OF THE EVALUATION IS REQUIRED TO RECEIVE CONTINUING EDUCATION CREDIT

Share with an interested colleague!

MATEC is committed to creating inclusive and accessible events.

To request an accommodation for an event or if you have any general questions,

please contact MATEC-KS/NE at stusher@kumc.edu

or MATEC-WI at matec@medicine.wisc.edu as soon as possible.



MATEC_blue_rgb-300x65.png

This program is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $3,660,874 with 0 percentage financed with nongovernmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government.